Perceptive Advisors Amends Trinity Biotech Stake
Ticker: TRIB · Form: SC 13D/A · Filed: Nov 14, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | SC 13D/A |
| Filed Date | Nov 14, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.0109 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, amendment
Related Tickers: TRNB
TL;DR
Perceptive Advisors filed an amendment on Trinity Biotech. Watch for potential moves.
AI Summary
Perceptive Advisors LLC, along with group members Joseph Edelman and other Perceptive entities, filed an amendment (SC 13D/A) on November 14, 2024, regarding their holdings in Trinity Biotech plc. The filing indicates a change in their beneficial ownership of the company's Class A Ordinary Shares.
Why It Matters
This filing signals a potential shift in the ownership structure or strategy of Trinity Biotech plc, which could impact its stock performance and future business decisions.
Risk Assessment
Risk Level: medium — Changes in beneficial ownership filings can indicate activist investor intentions or significant portfolio adjustments, carrying inherent market risk.
Key Players & Entities
- Perceptive Advisors LLC (company) — Filing entity
- Trinity Biotech plc (company) — Subject company
- Joseph Edelman (person) — Group member
- Perceptive Credit Advisors LLC (company) — Group member
- Perceptive Credit Holdings II, L.P. (company) — Group member
- Perceptive Credit Holdings III, L.P. (company) — Group member
- Alexander Rakitin (person) — Contact person for Perceptive Advisors LLC
FAQ
What specific changes in beneficial ownership are detailed in this SC 13D/A filing?
The filing is an amendment (Amendment No. 2) to a Schedule 13D, indicating a change in the beneficial ownership of Trinity Biotech plc's Class A Ordinary Shares by Perceptive Advisors LLC and its group members. Specific details of the change are not provided in the header information.
Who are the group members associated with Perceptive Advisors LLC in this filing?
The group members listed are Joseph Edelman, Perceptive Credit Advisors LLC, Perceptive Credit Holdings II, L.P., and Perceptive Credit Holdings III, L.P.
What is the subject company and its CUSIP number?
The subject company is Trinity Biotech plc, and its CUSIP number is 896438504.
When was this SC 13D/A filing submitted to the SEC?
The filing was submitted on November 14, 2024.
What is the business address of Trinity Biotech plc?
The business address of Trinity Biotech plc is IDA Business Park, Bray, Co Wicklow, Ireland.
Filing Stats: 1,646 words · 7 min read · ~5 pages · Grade level 8.5 · Accepted 2024-11-14 17:26:28
Key Financial Figures
- $0.0109 — e of Issuer) Class A Ordinary Shares, $0.0109 par value per share (Title of Class o
Filing Documents
- d879098dsc13da.htm (SC 13D/A) — 88KB
- 0001193125-24-258807.txt ( ) — 90KB
of the Schedule 13D is amended and supplemented as follows
Item 2 of the Schedule 13D is amended and supplemented as follows: (a) This Amendment No. 1 to the Schedule 13D is being filed by Perceptive Advisors LLC ( Perceptive Advisors or Perceptive ), Perceptive Credit Advisors LLC ( Perceptive Credit Advisors ), Joseph Edelman ( Mr. Edelman ), Perceptive Credit Holdings II, L.P. ( Credit Fund II ) and Perceptive Credit Holdings III, L.P. ( Credit Fund III , and together with Perceptive Advisors, Perceptive Credit Advisors, Mr. Edelman and Credit Fund II, each of the foregoing, a Reporting Person, and collectively, the Reporting Persons ). Perceptive Credit Advisors serves as the investment advisor to each of Credit Fund II and Credit Fund III and as relying advisor under Perceptive Advisors. Perceptive Credit Opportunities GP, LLC is the general partner of each of Credit Fund II and Credit Fund III. Mr. Edelman is the managing member of Perceptive Credit Advisors. The agreement among the Reporting Persons to jointly file this Amendment No. 2 to the Schedule 13D in accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, is attached as Exhibit 5 to Amendment No. 1 to the Schedule 13D filed on May 1, 2024. (b) The address of the principal business office of each of the Reporting Persons is 51 Astor Place 10th Floor, New York, NY 10003. (c) The principal business of Perceptive Advisors is managing funds in connection with purchasing, holding and selling securities for investment purposes. The principal business of Perceptive Credit Advisors is managing funds engaged in lending. The principal business of each of Credit Fund II and Credit Fund III are to engage in lending. The principal occupation of Mr. Edelman is as the managing member of Perceptive Advisors and other related entities. (d) During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the last five years, none of th
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: November 14, 2024 PERCEPTIVE ADVISORS LLC By: /s/ Joseph Edelman Name: Joseph Edelman Title: Managing Member PERCEPTIVE CREDIT ADVISORS LLC By: /s/ Joseph Edelman Name: Joseph Edelman Title: Managing Member /s/ Joseph Edelman JOSEPH EDELMAN PERCEPTIVE CREDIT HOLDINGS II, L.P. By: Perceptive Credit Opportunities GP, LLC, its general partner By: /s/ Joseph Edelman Name: Joseph Edelman Title: Managing Member PERCEPTIVE CREDIT HOLDINGS III, L.P. By: Perceptive Credit Opportunities GP, LLC, its general partner By: /s/ Joseph Edelman Name: Joseph Edelman Title: Managing Member